| 1 |
Hazel Joan Dyke |
Darwin Discovery Limited |
5 |
| 1 |
Fiona Wilson |
Aceaxis Limited |
5 |
| 3 |
David Cottam |
Teva Pharmaceutical Industries |
4 |
| #4 |
Stephen Price |
Genentech |
3 |
| #4 |
Lilian Alcaraz |
Astrazeneca Ab |
3 |
| #4 |
Susan Mary Cramp |
Zafgen |
3 |
| #4 |
Calum Macleod |
Johnson & Johnson |
3 |
| #8 |
Andrew Stephen Robert Jennings |
Chiesi Farmaceutici S.P.A. |
2 |
| #8 |
Susan Marie Westaway |
Glaxo Group Limited |
2 |
| #8 |
Simon Charles Goodacre |
Genentech |
2 |
| #8 |
Terry Aaron Panchal |
Chiesi Farmaceutici S.P.A. |
2 |
| #8 |
Christopher Hurley |
Chiesi Farmaceutici S.P.A. |
2 |
| #8 |
Michael Lainchbury |
Genentech |
2 |
| #14 |
David John VIRLEY |
Axovant Sciences Gmbh |
1 |
| #14 |
Sussie Lerche Krintel |
Genentech |
1 |
| #14 |
Tsu Tshen CHUANG |
Axovant Sciences Gmbh |
1 |
| #14 |
Robert James Gleave |
Convergence Pharmaceuticals Limited |
1 |
| #14 |
Francis Dominic Sanderson |
Glaxo Group Limited |
1 |
| #14 |
Graham Elgin Jones |
Smithkline Beeacham P.L.C. |
1 |
| #14 |
Daniel Lenart |
— |
1 |
| #14 |
Andrew Jennings |
Merck |
1 |
| #14 |
Nicolas Bertheleme |
Convergence Pharmaceuticals Limited |
1 |
| #14 |
Ann Jacqueline HUNTER |
Axovant Sciences Gmbh |
1 |
| #14 |
Simon Gaines |
Glaxo Group Limited |
1 |
| #14 |
Peter Kay |
Glaxosmithkline |
1 |
| #14 |
Lynne Patricia Crawford |
Schlumberger Technology |
1 |
| #14 |
Monique Bodil Van Niel |
Merck |
1 |
| #14 |
Justian Craig Fox |
Domantis Limited |
1 |
| #14 |
Frank Hossner |
Glaxo Group Limited |
1 |
| #14 |
Neville James McLean |
Genentech |
1 |
| #14 |
Paul Darrell |
Ford |
1 |